Your browser doesn't support javascript.
loading
BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification.
Barnett, Sarah E; Kenyani, Jenna; Tripari, Martina; Butt, Zohra; Grosman, Rudi; Querques, Francesca; Shaw, Liam; Silva, Luisa C; Goate, Zoe; Marciniak, Stefan J; Rassl, Doris M; Jackson, Richard; Lian, Lu-Yun; Szlosarek, Peter W; Sacco, Joseph J; Coulson, Judy M.
Affiliation
  • Barnett SE; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Kenyani J; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Tripari M; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Butt Z; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Grosman R; Biochemistry and Systems Biology, University of Liverpool, Liverpool, United Kingdom.
  • Querques F; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Shaw L; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Silva LC; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Goate Z; Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, United Kingdom.
  • Marciniak SJ; Cambridge Institute for Medical Research, Cambridge, United Kingdom.
  • Rassl DM; Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
  • Jackson R; Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
  • Lian LY; Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Szlosarek PW; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, United Kingdom.
  • Sacco JJ; Biochemistry and Systems Biology, University of Liverpool, Liverpool, United Kingdom.
  • Coulson JM; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Mol Cancer Res ; 21(5): 411-427, 2023 05 01.
Article in En | MEDLINE | ID: mdl-36669126
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesothelioma, Malignant / Mesothelioma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesothelioma, Malignant / Mesothelioma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication: